0910-AC12 200204 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Revocation of Conditions for Marketing Digoxin Products for Oral Use Substantive, Nonsignificant Previously Published in The Unified Agenda Final Rule Stage No No 21 CFR 310.500 21 USC 321 21 USC 331 21 USC 351 to 353 21 USC 355 21 USC 360b-f 21 USC 360j 21 USC 361a 21 USC 371 21 USC 374 21 USC 375 21 USC 379e 42 USC 216 42 USC 241 42 USC 242a 42 USC 262 42 USC 263b-n No NPRM 11/24/2000 65 FR 70538 Final Rule 10/00/2002 Undetermined Businesses None No NA Not Collected Mary Catchings E. 0910 Food and Drug Administration FDA 301 594-2041 301 827-0951 HFD-7, Center for Drug Evaluation and Research, 1451 Rockville Pike, Rockville MD 20852 Not Procurement Related No